Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24267

1.

Effect of Argemone mexicana (L.) against lithium-pilocarpine induced status epilepticus and oxidative stress in Wistar rats.

Asuntha G, Raju YP, Sundaresan CR, Rasheed A, Chowdary VH, Vandana KR, Babu KS, Prasad KV.

Indian J Exp Biol. 2015 Jan;53(1):31-5.

PMID:
25675709
2.

Rave drug tested against depression.

Reardon S.

Nature. 2015 Jan 8;517(7533):130-1. doi: 10.1038/517130a. No abstract available.

PMID:
25567262
3.

Antidepressant use in Canada has stopped increasing.

Patten SB, Williams JV, Lavorato DH, Fiest KM, Bulloch AG, Wang J.

Can J Psychiatry. 2014 Nov;59(11):609-14.

PMID:
25565477
4.

Reversal of non-suppression of cortisol levels in a patient with refractory depression receiving ketamine.

Ostroff R, Kothari JS.

Am J Psychiatry. 2015 Jan;172(1):95-6. doi: 10.1176/appi.ajp.2014.14060776. No abstract available.

PMID:
25553498
5.

Depression in Parkinson's disease.

Rihmer Z, Gonda X, Döme P.

Ideggyogy Sz. 2014 Jul 30;67(7-8):229-36. Review.

PMID:
25509363
6.

Biomarkers for assessing population and individual health and disease related to stress and adaptation.

McEwen BS.

Metabolism. 2015 Mar;64(3 Suppl 1):S2-S10. doi: 10.1016/j.metabol.2014.10.029. Epub 2014 Oct 30. Review.

PMID:
25496803
7.

In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography.

Comley RA, van der Aart J, Gulyás B, Garnier M, Iavarone L, Halldin C, Rabiner EA.

Neuropharmacology. 2015 May;92:44-8. doi: 10.1016/j.neuropharm.2014.11.017. Epub 2014 Dec 2.

PMID:
25476970
8.

QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice.

Kurhe Y, Mahesh R, Devadoss T.

Biochem Biophys Res Commun. 2015 Jan 2;456(1):74-9. doi: 10.1016/j.bbrc.2014.11.036. Epub 2014 Nov 21.

PMID:
25446100
9.

Short-term oral atrazine exposure alters the plasma metabolome of male C57BL/6 mice and disrupts α-linolenate, tryptophan, tyrosine and other major metabolic pathways.

Lin Z, Roede JR, He C, Jones DP, Filipov NM.

Toxicology. 2014 Dec 4;326:130-41. doi: 10.1016/j.tox.2014.11.001. Epub 2014 Nov 4.

PMID:
25445803
10.

Anxiolytic effects of orcinol glucoside and orcinol monohydrate in mice.

Wang X, Li G, Li P, Huang L, Huang J, Zhai H.

Pharm Biol. 2014 Nov 28:1-6. [Epub ahead of print]

PMID:
25429891
11.

Depression: a change of mind.

Anthes E.

Nature. 2014 Nov 13;515(7526):185-7. doi: 10.1038/515185a. No abstract available.

PMID:
25391944
12.

Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator.

Vanelderen P, Van Zundert J, Kozicz T, Puylaert M, De Vooght P, Mestrum R, Heylen R, Roubos E, Vissers K.

Anesthesiology. 2015 Feb;122(2):399-406. doi: 10.1097/ALN.0000000000000508.

PMID:
25373391
13.

Neuroscience. Jump-starting natural resilience reverses stress susceptibility.

Friedman A.

Science. 2014 Oct 31;346(6209):555. doi: 10.1126/science.1260781. No abstract available.

14.
15.

Toxic leukoencephalopathy in the intensive care unit.

Holyoak AL, Trout MJ, White RP, Prematuranga S, Senthuran S.

Anaesth Intensive Care. 2014 Nov;42(6):782-8.

PMID:
25342412
16.

Sertraline influence on morphine-induced conditioned place preference in rats.

Ciubotariu D, Nechifor M.

Rev Med Chir Soc Med Nat Iasi. 2014 Jul-Sep;118(3):712-6.

PMID:
25341290
17.

Effects of ouabain on cytokine/chemokine levels in an animal model of mania.

Tonin PT, Valvassori SS, Lopes-Borges J, Mariot E, Varela RB, Teixeira AL, Quevedo J.

J Neuroimmunol. 2014 Nov 15;276(1-2):236-9. doi: 10.1016/j.jneuroim.2014.09.007. Epub 2014 Sep 17.

PMID:
25288301
18.

Effects of dopaminergic agents on progression of naturally occurring myopia in albino guinea pigs (Cavia porcellus).

Jiang L, Long K, Schaeffel F, Zhou X, Zheng Y, Ying H, Lu F, Stell WK, Qu J.

Invest Ophthalmol Vis Sci. 2014 Sep 30;55(11):7508-19. doi: 10.1167/iovs.14-14294.

PMID:
25270191
19.

Differential modulation of reinforcement learning by D2 dopamine and NMDA glutamate receptor antagonism.

Jocham G, Klein TA, Ullsperger M.

J Neurosci. 2014 Sep 24;34(39):13151-62. doi: 10.1523/JNEUROSCI.0757-14.2014.

20.

Mood regulation. GABA/glutamate co-release controls habenula output and is modified by antidepressant treatment.

Shabel SJ, Proulx CD, Piriz J, Malinow R.

Science. 2014 Sep 19;345(6203):1494-8. doi: 10.1126/science.1250469. Epub 2014 Sep 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk